Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 31-Mar-2022 titled Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg.
Promoter/Promoter Group of Speciality Restaurants Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Sundaram Brake Linings Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Tree House Education & Accessories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that Shri Atul Baburao Patil has been appointed as an Additional Director [Director (Marketing)] on the Board of the Company w.e.f. 07.04.2022 in terms of Order No. 82/1/2021-HR-PSU (part) dated 25th March, 2022 issued by Department of Fertilizers, Ministry of Chemicals & Fertilizers, Government of India (copy of order enclosed).Brief profile of Shri Atul Baburao Patil is enclosed as Annexure-1. We request you to kindly take the above on record.
Promoter/Promoter Group of Supriya Lifescience Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of GTL Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Jtekt India Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Future Supply Chain Solutions Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Promoter/Promoter Group of Time Technoplast Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
